| Stage | MSCI | % of rev | AZO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $892M | 100.00% | $6.6B | 100.00% | AZO ×7.39 |
| Gross profit | $740M | 82.94% | $3.5B | 53.34% | MSCI +29.6pp |
| Operating income | $502M | 56.29% | $1.3B | 19.97% | MSCI +36.3pp |
| Pre-tax income | $428M | 47.97% | $1.2B | 17.71% | MSCI +30.3pp |
| Net income | $351M | 39.35% | $932M | 14.13% | MSCI +25.2pp |
| Stage | MSCI | AZO | Gap · A − B |
|---|---|---|---|
| Revenue | $892M100.00% | $6.6B100.00% | AZO ×7.39 |
| Gross profit | 82.94%$740M | 53.34%$3.5B | MSCI +29.6pp |
| Operating income | 56.29%$502M | 19.97%$1.3B | MSCI +36.3pp |
| Pre-tax income | 47.97%$428M | 17.71%$1.2B | MSCI +30.3pp |
| Net income |
| 39.35%$351M |
| 14.13%$932M |
| MSCI +25.2pp |
No shared counterparties.